Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S)

被引:11
作者
Bodamer, OAF
Church, HJ
Cooper, A
Wraith, JE
Scott, CR
Scaglia, F
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Univ Hosp Vienna, Dept Pediat, Vienna, Austria
[3] Manchester Childrens Hosp NHS Trust, Willink Biochem Genet Unit, Manchester, Lancs, England
[4] Univ Washington, Childrens Hosp & Med Ctr, Dept Pediat, Seattle, WA USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 109卷 / 04期
关键词
beta-glucosidase deficiency; variant neuronopathic form; genotypic and phenotypic variability;
D O I
10.1002/ajmg.10385
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A 20-month-old girl with developmental delay, dysmorphic features, horizontal supranuclear gaze palsy, retrocollis, and episodes of laryngospasm was diagnosed with variant neuronopathic Gaucher disease. The diagnosis was made enzymatically. Mutation analysis showed compound heterozygosity for D409H and a previously unreported mutation C16S. The presence of dysmorphic features, laryngospasm, absent cardiac findings, and the severe clinical phenotype distinguishes our case from other cases of variant neuronopathic Gaucher disease. We therefore propose to extend the spectrum of variant Gaucher disease. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:328 / 331
页数:4
相关论文
共 14 条
[1]   GAUCHERS-DISEASE VARIANT CHARACTERIZED BY PROGRESSIVE CALCIFICATION OF HEART-VALVES AND UNIQUE GENOTYPE [J].
ABRAHAMOV, A ;
ELSTEIN, D ;
GROSSTSUR, V ;
FARBER, B ;
GLASER, Y ;
HADASHALPERN, I ;
RONEN, S ;
TAFAKJDI, M ;
HOROWITZ, M ;
ZIMRAN, A .
LANCET, 1995, 346 (8981) :1000-1003
[2]   The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease [J].
Altarescu, G ;
Hill, S ;
Wiggs, E ;
Jeffries, N ;
Kreps, C ;
Parker , CC ;
Brady, RO ;
Barton, NW ;
Schiffmann, R ;
Bannarjee, TK ;
Crutchfield, K ;
Frei, K ;
McKee, MA ;
Moore, DF ;
Tournay, A .
JOURNAL OF PEDIATRICS, 2001, 138 (04) :539-547
[3]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[4]   Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC) [J].
Bohlega, S ;
Kambouris, M ;
Shahid, M ;
Al Homsi, M ;
Al Sous, W .
NEUROLOGY, 2000, 54 (01) :261-263
[5]   UNUSUAL EXPRESSION OF GAUCHERS-DISEASE - CARDIOVASCULAR CALCIFICATIONS IN 3 SIBS HOMOZYGOUS FOR THE D409H MUTATION [J].
CHABAS, A ;
CORMAND, B ;
GRINBERG, D ;
BURGUERA, JM ;
BALCELLS, S ;
MERINO, JL ;
MATE, I ;
SOBRINO, JA ;
GONZALEZDUARTE, R ;
VILAGELIU, L .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (09) :740-742
[6]   A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules [J].
Inui, K ;
Yanagihara, K ;
Otani, K ;
Suzuki, Y ;
Akagi, M ;
Nakayama, M ;
Ida, H ;
Okada, S .
JOURNAL OF PEDIATRICS, 2001, 138 (01) :137-139
[7]   Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease [J].
Koprivica, V ;
Stone, DL ;
Park, JK ;
Callahan, M ;
Frisch, A ;
Cohen, IJ ;
Tayebi, N ;
Sidransky, E .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) :1777-1786
[8]  
LATHAM T, 1990, AM J HUM GENET, V47, P79
[9]   Type II Gaucher disease:: Compound heterozygote with RecNcil and L444P mutations [J].
Lee, YS ;
Poh, LKS ;
Ida, H ;
Loke, KY .
JOURNAL OF TROPICAL PEDIATRICS, 2001, 47 (02) :115-117
[10]   Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency:: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant [J].
Pàmpols, T ;
Pineda, M ;
Girós, ML ;
Ferrer, I ;
Cusi, V ;
Chabás, A ;
Sanmarti, FX ;
Vanier, MT ;
Christomanou, H .
ACTA NEUROPATHOLOGICA, 1999, 97 (01) :91-97